Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency.

Autor: van der Loo JC; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA. Han.vanderloo@cchmc.org, Swaney WP, Grassman E, Terwilliger A, Higashimoto T, Schambach A, Hacein-Bey-Abina S, Nordling DL, Cavazzana-Calvo M, Thrasher AJ, Williams DA, Reeves L, Malik P

Publikováno v: Gene therapy [Gene Ther] 2012 Aug; Vol. 19 (8), pp. 872-6. Date of Electronic Publication: 2012 May 03.

Simple viral/minimal piggyBac hybrid vectors for stable production of self-inactivating gamma-retroviruses.

Autor: Troyanovsky, Boris¹, Bitko, Vira², Fouty, Brian^3,4,5, Solodushko, Victor^3,4 vsolodushko@southalabama.edu

Publikováno v: BMC Research Notes. Aug2015, Vol. 8 Issue 1, p1-7. 7p. 1 Diagram, 1 Chart, 3 Graphs.